IAIM
BMRN icon

International Assets Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

International Assets Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-262
Closed -$18.4K – 951
2024
Q3 		$18.4K Buy
+262
New +$21.9K ﹤0.01% 1400
2021
Q2 		– Sell
-32
Closed -$3K – 668
2021
Q1 		$3K Hold
32
– – ﹤0.01% 1912
2020
Q4 		$3K Buy
+32
New +$2.54K ﹤0.01% 1767

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

International Assets Investment Management's BMRN Position: Q4 2024 in Review

International Assets Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2024, closing a stake of 262 shares — an estimated $18.4K sold.

International Assets Investment Management first reported a position in BMRN in Q4 2020 and held it in 3 quarters. The position peaked at $18.4K in Q3 2024. 545 funds tracked by Wall St. Rank hold BMRN as of Q4 2024.

  • International Assets Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 262 BioMarin Pharmaceuticals shares in Q4 2024, an estimated $18.4K.
  • International Assets Investment Management first reported a position in BioMarin Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • International Assets Investment Management's BioMarin Pharmaceuticals position peaked at $18.4K in Q3 2024.
  • 545 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.